Product News and Recalls

Brain may be more repairable than previously thought

New findings suggest the brain may have more ability to repair itself than previously thought, leading researchers to speculate that a new approach to treatment may be imminent.

According to a report in Diagnostic Imaging, Michael Lipton, MD, associate director of the Gruss Magnetic Resonance Research Center at the Albert Einstein College of Medicine, revealed his research at a recent meeting of the Radiological Society of North America.

By using a ...

continue reading...

European agency approves controversial diabetes drug

A report on the blog FiercePharma says the European Medicines Agency – which evaluates medical products for the European Union – has approved an expanded use of the drug Byetta for type 2 diabetes patients.

Byetta is now approved for use with or without other medications such as metformin and Actos, to help adults who have been unable to get their blood sugars under control.

The decision was expected after an advisory ...

continue reading...

FDA says Januvia ‘misbranded’ because of late study

A report on the blog Pharmalot says the U.S. Food and Drug Administration has ruled that pharmaceutical company Merck was nearly two years late with a mandated study of its Januvia and Janument diabetes medications.

The FDA had instructed to Merck to conduct a post-marketing study after the agency revised prescribing information for the drugs in 2009 to include 88 cases of acute pancreatitis between 2006 and 2009.

A subsequent study linked Januvia and another diabetes drug, Byetta, with a higher risk ...

continue reading...

Medical journals print biased studies

An article in the Washington Post says major medical journals routinely print studies over which pharmaceutical companies can exert major influence. That company influence “has become a common practice that reflects the growing role of industry money in research,” the article says.

As an example, the Washington Post cites a 17-page article in the New England Journal of Medicine that rated GlaxoSmithKline’s Avandia the best of three diabetes drugs. GlaxoSmithKline funded the trial that formed the basis of the article, and ...

continue reading...

Patients believe outbreak wider than reported

The scope of a deadly outbreak linked to a Massachusetts pharmacy may be wider than initially thought, the U.S. Food and Drug Administration reports. And now some patients who received medications from that pharmacy suspect health officials may be undercounting the number of infections they’ve caused.

The New England Compounding Center produced the medication blamed for the outbreak, methylprednisolone acetate, which is a steroid injected into the ...

continue reading...

Meningitis outbreak prompts call for more inspections

In light of a deadly meningitis outbreak, public health watchdog group “Public Citizen” is calling on the U.S. Food and Drug Administration to re-inspect more than a dozen compounding pharmacies with prior records of violations, the Seattle Times reports.

Compounding pharmacies mix customized medications based on doctors’ instructions. One of those specialized pharmacies, the New England Compounding Center in Massachusetts, was the source of contaminated steroid medication ...

continue reading...
Page 281 of 386 «...250260270279280281282283...»